Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
BMO Capital Markets reissued a market perform rating and issued a $31.00 price objective on shares of ImmunoGen in a research note on Friday.
Equities analysts anticipate that ImmunoGen will post -0.93 EPS for the current fiscal year.
Raymond James Financial Services Advisors Inc. boosted its stake in shares of ImmunoGen by 20.8% during the 1st quarter.
The second combination cohort in ovarian cancer is the result of collaboration between Shattuck and ImmunoGen.